ERBB2 and breast carcinoma: Identifying the relationship between HER2 expression and chemotherapy response provides both potential treatment targets for chemotherapy nonresponse and a clinical-relevant approach with molecular imaging to predict and guide therapeutic interventions in breast cancer.